Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Odyssey Therapeutics, Inc. See All Filings	D	2025-12-04 14:51:33 UTC
Amount To Be Raised $214,025,200 Associated Brokers / Dealers N/A CIK Number 0001882782 Filed Document 0001104659-25-118426 Exclusions or Exemptions 506b Accepted Date 2025-12-04 14:51:33 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Odyssey Therapeutics, Inc. See All Filings	D/A	2024-08-14 12:26:06 UTC
Amount To Be Raised $121,080,000 Associated Brokers / Dealers N/A CIK Number 0001882782 Filed Document 0001882782-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-08-14 12:26:06 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Odyssey Therapeutics, Inc. See All Filings	D	2023-12-15 16:17:28 UTC
Amount To Be Raised $106,000,000 Associated Brokers / Dealers N/A CIK Number 0001882782 Filed Document 0001882782-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-12-15 16:17:28 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Odyssey Therapeutics, Inc. See All Filings	D	2022-10-27 09:30:39 UTC
Amount To Be Raised $174,909,939 Associated Brokers / Dealers N/A CIK Number 0001882782 Filed Document 0001882782-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-10-27 09:30:39 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Odyssey Therapeutics, Inc. See All Filings	D	2021-10-14 16:34:12 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001882782 Filed Document 0001882782-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-10-14 16:34:12 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity